Joanna Kimberley Duncan

Title: Joanna Kimberley Duncan: Innovator in Cysteine Protease Inhibitors

Introduction

Joanna Kimberley Duncan is a notable inventor based in Christchurch, New Zealand. She has made significant contributions to the field of biochemistry, particularly in the development of macrocyclic compounds that serve as cysteine protease inhibitors. With a total of 2 patents to her name, her work is paving the way for advancements in pharmaceutical compositions.

Latest Patents

Duncan's latest patents focus on macrocyclic cysteine protease inhibitors and compositions thereof. The present invention provides a novel class of macrocyclic compounds that are useful as cysteine protease inhibitors. Additionally, it includes novel intermediates and methods for preparing these compounds. The invention also offers pharmaceutical compositions comprising the compounds, which are beneficial in treating or preventing diseases associated with cysteine protease activity, particularly those linked to calpain activity.

Career Highlights

Throughout her career, Joanna has worked with esteemed organizations such as Lincoln University and Douglas Pharmaceuticals Limited. Her research and innovations have garnered attention in the scientific community, contributing to the understanding and treatment of various diseases.

Collaborations

Duncan has collaborated with notable colleagues, including Andrew David Abell and James Morriss Coxon. These partnerships have further enriched her research and development efforts in the field of biochemistry.

Conclusion

Joanna Kimberley Duncan's work in developing macrocyclic cysteine protease inhibitors showcases her innovative spirit and dedication to advancing medical science. Her contributions are significant in the ongoing quest to find effective treatments for diseases related to cysteine protease activity.